These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 27774443

  • 1. The Utility of Fecal Calprotectin in the Real-World Clinical Care of Patients with Inflammatory Bowel Disease.
    Abej E, El-Matary W, Singh H, Bernstein CN.
    Can J Gastroenterol Hepatol; 2016; 2016():2483261. PubMed ID: 27774443
    [Abstract] [Full Text] [Related]

  • 2. Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases.
    Nancey S, Boschetti G, Moussata D, Cotte E, Peyras J, Cuerq C, Haybrard J, Charlois AL, Mialon A, Chauvenet M, Stroeymeyt K, Kaiserlian D, Drai J, Flourié B.
    Inflamm Bowel Dis; 2013 Apr; 19(5):1043-52. PubMed ID: 23511035
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic Accuracy of Fecal Calprotectin for Pediatric Inflammatory Bowel Disease in Primary Care: A Prospective Cohort Study.
    Holtman GA, Lisman-van Leeuwen Y, Kollen BJ, Norbruis OF, Escher JC, Kindermann A, de Rijke YB, van Rheenen PF, Berger MY.
    Ann Fam Med; 2016 Sep; 14(5):437-45. PubMed ID: 27621160
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers.
    Ricanek P, Brackmann S, Perminow G, Lyckander LG, Sponheim J, Holme O, Høie O, Rydning A, Vatn MH, IBSEN II Study Group.
    Scand J Gastroenterol; 2011 Sep; 46(9):1081-91. PubMed ID: 21619483
    [Abstract] [Full Text] [Related]

  • 5. Fecal Immunochemical Test Versus Fecal Calprotectin for Prediction of Mucosal Healing in Crohn's Disease.
    Inokuchi T, Kato J, Hiraoka S, Takashima S, Nakarai A, Takei D, Sugihara Y, Takahara M, Kawano S, Harada K, Okada H.
    Inflamm Bowel Dis; 2016 May; 22(5):1078-85. PubMed ID: 26891256
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin Vs. Fecal Immunochemical Test.
    Takashima S, Kato J, Hiraoka S, Nakarai A, Takei D, Inokuchi T, Sugihara Y, Takahara M, Harada K, Okada H, Tanaka T, Yamamoto K.
    Am J Gastroenterol; 2015 Jun; 110(6):873-80. PubMed ID: 25823769
    [Abstract] [Full Text] [Related]

  • 7. Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn's disease.
    E Penna FGC, Rosa RM, da Cunha PFS, de Souza SCS, de Abreu Ferrari ML.
    BMC Gastroenterol; 2020 Feb 13; 20(1):35. PubMed ID: 32054445
    [Abstract] [Full Text] [Related]

  • 8. Relationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease.
    Hoekman DR, Diederen K, Koot BG, Tabbers MM, Kindermann A, Benninga MA.
    Eur J Pediatr; 2016 Oct 13; 175(10):1335-42. PubMed ID: 27573259
    [Abstract] [Full Text] [Related]

  • 9. Fecal calprotectin is equally sensitive in Crohn's disease affecting the small bowel and colon.
    Jensen MD, Kjeldsen J, Nathan T.
    Scand J Gastroenterol; 2011 Jun 13; 46(6):694-700. PubMed ID: 21456899
    [Abstract] [Full Text] [Related]

  • 10. Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis-a Prospective Analysis.
    Walsh A, Kormilitzin A, Hinds C, Sexton V, Brain O, Keshav S, Uhlig H, Geddes J, Goodwin G, Peters M, Collins G, Travis S.
    J Crohns Colitis; 2019 Mar 30; 13(4):424-430. PubMed ID: 30445625
    [Abstract] [Full Text] [Related]

  • 11. The use of serum calprotectin as a biomarker for inflammatory activity in inflammatory bowel disease.
    Suárez Ferrer C, Abadía Barno M, Martín Arranz E, Jochems A, García Ramírez L, Poza Cordón J, Jaquotot Herranz M, Cerpa Arencibia A, Martín Arranz MD.
    Rev Esp Enferm Dig; 2019 Oct 30; 111(10):744-749. PubMed ID: 31476872
    [Abstract] [Full Text] [Related]

  • 12. Rapid Fecal Calprotectin Test and Symptom Index in Monitoring the Disease Activity in Colonic Inflammatory Bowel Disease.
    Puolanne AM, Kolho KL, Alfthan H, Ristimäki A, Mustonen H, Färkkilä M.
    Dig Dis Sci; 2017 Nov 30; 62(11):3123-3130. PubMed ID: 28948412
    [Abstract] [Full Text] [Related]

  • 13. Faecal Biomarkers in Inflammatory Bowel Diseases: Calprotectin Versus Lipocalin-2-a Comparative Study.
    Zollner A, Schmiderer A, Reider SJ, Oberhuber G, Pfister A, Texler B, Watschinger C, Koch R, Effenberger M, Raine T, Tilg H, Moschen AR.
    J Crohns Colitis; 2021 Jan 13; 15(1):43-54. PubMed ID: 32556317
    [Abstract] [Full Text] [Related]

  • 14. Detection of calprotectin in inflammatory bowel disease: Fecal and serum levels and immunohistochemical localization.
    Fukunaga S, Kuwaki K, Mitsuyama K, Takedatsu H, Yoshioka S, Yamasaki H, Yamauchi R, Mori A, Kakuma T, Tsuruta O, Torimura T.
    Int J Mol Med; 2018 Jan 13; 41(1):107-118. PubMed ID: 29115397
    [Abstract] [Full Text] [Related]

  • 15. Combined evaluation of biomarkers as predictor of maintained remission in Crohn's disease.
    Sollelis E, Quinard RM, Bouguen G, Goutte M, Goutorbe F, Bouvier D, Pereira B, Bommelaer G, Buisson A.
    World J Gastroenterol; 2019 May 21; 25(19):2354-2364. PubMed ID: 31148906
    [Abstract] [Full Text] [Related]

  • 16. TWEAK is not elevated in patients with newly diagnosed inflammatory bowel disease.
    Grimstad T, Skoie IM, Doerner J, Isaksen K, Karlsen L, Aabakken L, Omdal R, Putterman C.
    Scand J Gastroenterol; 2017 Apr 21; 52(4):420-424. PubMed ID: 28040992
    [Abstract] [Full Text] [Related]

  • 17. Fecal Human Neutrophil Peptide Levels Correlate with Intestinal Inflammation in Ulcerative Colitis.
    Kanmura S, Hamamoto H, Morinaga Y, Oda K, Fujita T, Arima S, Nasu Y, Sasaki F, Hashimoto S, Taguchi H, Setoyama H, Ido A.
    Digestion; 2016 Apr 21; 93(4):300-8. PubMed ID: 27220673
    [Abstract] [Full Text] [Related]

  • 18. Endoscopic Factors Influencing Fecal Calprotectin Value in Crohn's Disease.
    Goutorbe F, Goutte M, Minet-Quinard R, Boucher AL, Pereira B, Bommelaer G, Buisson A.
    J Crohns Colitis; 2015 Dec 21; 9(12):1113-9. PubMed ID: 26351383
    [Abstract] [Full Text] [Related]

  • 19. Fecal Calprotectin as an Activity Marker of Inflammatory Bowel Disease in Children.
    Krzesiek E.
    Adv Clin Exp Med; 2015 Dec 21; 24(5):815-22. PubMed ID: 26768632
    [Abstract] [Full Text] [Related]

  • 20. Prediction of treatment outcome and relapse in inflammatory bowel disease.
    Kato J, Yoshida T, Hiraoka S.
    Expert Rev Clin Immunol; 2019 Jun 21; 15(6):667-677. PubMed ID: 30873890
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.